Browse > Article

COH-IVF Outcomes for Infertile Patients With Borderline Ovarian Tumor After Conservative Treatment  

Lee, Hyun-Joo (Department of Obstetrics and Gynecology, Cheil General Hospital and Women's Healthcare Center Kwandong University, College of Medicine)
Ahn, Ka-Yougng (Department of Obstetrics and Gynecology, Cheil General Hospital and Women's Healthcare Center Kwandong University, College of Medicine)
Hahn, Ho-Suap (Department of Obstetrics and Gynecology, Cheil General Hospital and Women's Healthcare Center Kwandong University, College of Medicine)
Park, Chan-Woo (Division of Reproductive Endocrinology & Infertility, Cheil General Hospital and Women's Healthcare Center Kwandong University, College of Medicine)
Yang, Kwang-Moon (Division of Reproductive Endocrinology & Infertility, Cheil General Hospital and Women's Healthcare Center Kwandong University, College of Medicine)
Lee, In-Ho (Division of Gynecology Oncology, Cheil General Hospital and Women's Healthcare Center Kwandong University, College of Medicine)
Kim, Tae-Jin (Division of Gynecology Oncology, Cheil General Hospital and Women's Healthcare Center Kwandong University, College of Medicine)
Lim, Kyung-Taek (Division of Gynecology Oncology, Cheil General Hospital and Women's Healthcare Center Kwandong University, College of Medicine)
Lee, Ki-Heon (Division of Gynecology Oncology, Cheil General Hospital and Women's Healthcare Center Kwandong University, College of Medicine)
Kang, Inn-Soo (Division of Reproductive Endocrinology & Infertility, Cheil General Hospital and Women's Healthcare Center Kwandong University, College of Medicine)
Publication Information
Clinical and Experimental Reproductive Medicine / v.34, no.2, 2007 , pp. 87-94 More about this Journal
Abstract
Objective: To examine determinants of successful pregnancy and evaluate COH-IVF outcomes of infertile patients after conservative surgical treatment of borderline ovarian tumor (BOT). Methods: In women of BOT (n=93), from January 1995 to December 1999, 44 of 93 women underwent conservative surgical treatment. From theses 44 women, patients characteristics, surgical and histological parameters were compared between 14 women who conceived and 30 women who failed to conceive. For 5 infertile women of 30 women who failed to conceive, 10 attempt IVF cycles were analysed; clinical pregnancy rate (CPR), implantation rate (IR) and live birth rate (LBR). Results: Women who conceived tend to be younger (25.9 vs 27.0 years) and lower serum CA-125 level (59.7 vs 72.9) compared to women who failed to conceive without significant difference. For 8 cycles out of 10 attempt IVF cycles, except for 2 cancellation cycles, the mean number of oocytes retrieved was 5.6 (range 2$\sim$16) with a mean fertilization rate of 74.4%. The CPR, IR and LBR per embryo transfer were 50.0% (4/8 cycles), 31.6% (6/19) and 50.0% (4/8 cycles) respectively. During the mean follow-up period after COH-IVF initiation, 29.6 (range 14$\sim$61) months, no recurrence was found. Conclusion: No determinant of successful pregnancy was found after conservative treatment for BOT. COH-IVF may be considered for infertile patients after conservative treatment of BOT. However, larger clinical studies with longer follow-up are necessary to evaluate the safety and efficacy of COH-IVF. All patients should be informed of the potential risks associated with ovarian hyperstimulation and close follow-up is necessary after COH-IVF.
Keywords
Borderline ovarian tumors (BOT); Conservative surgical treatment; COH-IVF;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Lim-Tan SK, Cajigas HE, Scully RE. Ovarian cystectomy for serous borderline tumors: a follow-up study of 35 cases. Obstet Gynecol 1988; 72: 775-81   PUBMED
2 Ness RB, Cramer DW, Goodman MT, Kjaer SK, Mallin K, Mosgaard BJ, et al. Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. Am J Epidemiol 2002; 155: 217-24   DOI   ScienceOn
3 Shushan A, Paltiel O, Iscovich J, Elchalal U, Peretz T, Schenker JG, Human menopausal gonadotropin and the risk of epithelial ovarian cancer. Fertil Steril 1996; 65: 13-8   DOI   PUBMED
4 Harris R, Whittemore AS, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US casecontrol studies. III. Epithelial tumors of low malignant potential in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 1992; 136: 1204-11   DOI   PUBMED
5 Mantzavinos T, Kanakas N, Genatas C, Papadias K, Zourlas PA. Five years' follow-up in two patients with borderline tumours of the ovary hyperstimulated by gonadotrophin therapy for in-vitro fertilization. Hum Reprod 1994; 9: 20323
6 Madelenat P, Meneux E, Fernandez H, Uzan S, Antoine JM. Place de l' assistance a l' a procreation apres traitement conservateur d'une tumeur ovarienne: enquete multicentrique francaise. 10th Congres de la Societe Francaise d'Oncologie Gynecologique, Poitiers, France, 19995-6 November
7 Fauvet R, Poncelet C, Boccara J, Descamps P, Fondrinier E, Darai E. Fertility after conservative treatment for borderline ovarian tumors: A French multicenter study. Fertil Steril 2005; 83: 284-90   DOI   ScienceOn
8 Donnez J, Munschke A, Berliere M, Pirard C, Jadoul P, Smets M, et al. Safety of conservative management and fertility outcome in women with borderline tumors of the ovary. Fertil Steril 2003; 79: 1216-21   DOI   ScienceOn
9 Morris RT, Gershenson DM, Silva EG, Follen M, Morris M, Wharton JT. Outcome and reproductive function after conservative surgery for borderline ovarian tumors. Obstet Gynecol 2000; 95: 541-7   DOI   ScienceOn
10 Attar E, Berckman S, Topuz S, Baysal B, Akhan S, Chambers JT. Evolutive peritoneal disease after conservative management and the infertility drugs in a patient with stage IIIC borderline micropapillary serous carcinoma (MPSC) of the ovary: case report. Hum Reprod 2004; 19: 1472-5   DOI   ScienceOn
11 Servov SF, Scully RE, Sobin LH. Histology typing of ovarian tumors, in International histologic classification of tumors. Number 9 Geneva; World Health Organization 1973; 37-8
12 Fasouliotis S, Davis O, Schattman G, Spandorfer SD, Kigman I, Rosenwaks Z. Safety and efficacy of infertility treatment after 16 conservative management of borderline ovarian tumors: a preliminary report. Fertil Steril 2004; 82: 568-72   DOI   ScienceOn
13 Parazzini F, Negri E, La Vecchia C, Moroni S, Polatti A, Chiaffarino F, et al. Treatment for fertility and risk of ovarian tumors of borderline malignancy. Gynecol Oncol 1998; 68: 226-8   DOI   ScienceOn
14 Trope CG, Kristensen G, Makar A. Surgery for borderline tumor of the ovary. Semin Surg Oncol 2000; 19: 69-75   DOI   ScienceOn
15 Beiner ME, Gotlieb WH, Davidson B, Kopolovic J, Ben-Baruch G. Infertility treatment after conservative management of borderline ovarian tumors. Cancer 2001; 92: 320-5   DOI   ScienceOn
16 Classification and staging of malignant tumors in the female pelvis. Acta Obstet Gynecol Scand 1979; 50: 1-7
17 Hoffman JS, Laird L, Benadiva C, Dreiss R. In vitro fertilization following conservative management of stage 3 serous borderline tumor of the ovary. Gynecol Oncol 1999; 74: 515 -8   DOI   ScienceOn
18 Nijman HW, Burger CW, Baak JP, Schats R, Vermorken JB, Kenemans P. Borderline malignancy of the ovary and controlled hyperstimulation, a report of 2 cases. Eur J Cancer 1992; 12: 1971-3
19 Taylor HC. Malignant and semimalignant tumors of ovary. Surg Gynecol Obstet 1929; 48: 204-30
20 Whittemore AS, Harris R, Itnyre J and Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies; II, invasive epithelial ovarian cancer in white women. Am J Epidemiol 1992; 136: 1184-203   DOI   PUBMED
21 Hershkovitz R, Lunenfeld E, Piura B, Pak I, Leiberman JR, Yanai-Inbar I, et al. Ovulation induction in three infertile patients with ovarian tumor. Israel J Obstet Gynecol 1998; 9: 271-5
22 Rossing MA, Daling JR, Weiss NS, Moore DE, Self So. Ovarian tumors in a cohort of infertile women. N Engl J Med 1994; 331: 771-6   DOI   ScienceOn
23 Morice P, Camatte S, Hassan J, Pautier P, Duvillard P, Castaigne D. Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors. Fertil Steril 2001; 75: 92-6   DOI   ScienceOn
24 Trimble CL, Trimble EL. Management of epithelial ovarian tumors of low malignant potential. Gynecol Oncol 1994; 55: 52-61   DOI   ScienceOn